Buy the dip in this MedTech stock says Citi
As per analysts at Citi Research in a note dated Wednesday, the recent decline in Boston Scientific’s stock presents a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
